NEW

DePuy Synthes Receives 510(k) FDA Clearance for VELYS™ Robotic-Assisted Solution Designed for Use with the ATTUNE Total Knee System

The Johnson & Johnson Medical Devices Companies announced that DePuy Synthes has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the VELYS Robotic-Assisted Solution designed for use with the ATTUNE® Total Knee System and its cleared indications for use.

Philips to Acquire Capsule Technologies Inc.

Royal Philips has signed an agreement to acquire Capsule Technologies Inc., a provider of medical device integration and data technologies for hospitals and healthcare organizations.

Camber Spine Expands Patent Portfolio with SPIRA Lateral 3.0

Camber Spine has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for its SPIRA Lateral 3.0 interbody fusion implant.

UVDI-360 Room Sanitizer Inactivates SARS-CoV-2 at 12 Feet Distance in 5 Minutes

UltraViolet Devices Inc. (UVDI) has announced that its UVDI-360 Room Sanitizer achieved greater than 99.99%, or 4log10, inactivation of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in 5 minutes at a distance of 12 feet (3.65 meters).

ECRI Helps Reduce Costs Amid Pandemic

ECRI recently released an enhanced value analysis workflow solution that drives team transparency, clinical engagement and improves efficiency of the medical product decision-making process. ECRI’s Value Analysis Workflow empowers supply chain leaders, value analysis teams and clinicians to reach consensus on complex technology purchasing decisions based on sound clinical evidence.

“The COVID-19 pandemic is tightening financial pressures on an already strained health care system,” says Marcus Schabacker, MD, PhD, president and CEO, ECRI. “Our new value analysis workflow adds much-needed transparency, safety and clinical evidence assurance that leaders can rely on to stretch scarce resources when selecting new patient-care technologies.”

ECRI’s Value Analysis Workflow integrates pricing and utilization analytics, evidence-based assessments and comparative product evaluations to reduce clinical spend and enhance patient outcomes.

The cloud-based project management tool includes three major enhancements:

  1. Visual workflow. Increases efficiency by providing organization-level transparency on the status of any project under consideration
  2. Mobile notifications. Makes it easy for clinicians and value analysis members to review, research and approve project tasks directly from mobile devices
  3. Automated decision logic. Automatically routes supporting financial, technical or clinical evidence to the correct person for approval ensuring the right people are making the best decisions

The workflow application adds efficiency by integrating clinicians and all members of the value analysis team into the process, streamlining decisions. Hospital Sisters Health System, a multi-institutional health care system in Illinois and Wisconsin, shortened request turn-around times by 76 percent, reducing the time to completion to approximately 14 to 18 days.

“Unlike other workflow solutions, ECRI embeds trusted, unbiased clinical evidence analysis and guidance into our services to inform clinical decisions and improve patient outcomes,” says Karen Schoelles, MD, vice president, clinical excellence and safety, ECRI.

This latest product release enhances ECRI’s proven suite of technology decision-making tools and personalized services that help hospital leaders achieve immediate cost savings without compromising patient care. Thousands of health care organizations worldwide rely on ECRI’s experience in delivering strategic, evidence-based technology management guidance.

ECRI is actively assisting health care organizations with COVID-19 preparedness resources and services. Its public-access COVID-19 Resource Center includes best practices for infection prevention, medical device guidance on PPE, ventilators, and infusion therapies, and clinical evidence assessments on coronavirus-related treatments, therapies, and interventions. ECRI is also providing members with open access to COVID-19 recovery-related guidance, tools and resources across its entire solution suite.

To learn more about ECRI’s Value Analysis Workflow or to request a demo, contact ECRI at 610-825-6000 or clientservices@ecri.org.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X